Celecoxib nanoemulsion: Skin permeation mechanism and bioavailability assessment

Journal of Drug Targeting

Volumn 16, Issue 10, 2008, Pages 733-740

  Shakeel, Faiyaz ^a   Baboota, Sanjula ^b   Ahuja, Alka ^b   Ali, Javed ^b   Shafiq, Sheikh ^c  

^a Al Arab Medical Sciences University   (Libyan Arab Jamahiriya)

^b HAMDARD UNIVERSITY   (India)

^c ZYDUS RESEARCH CENTRE   (India)

Author keywords

Bioavailability; Celecoxib; Nanoemulsion; Skin permeation mechanism

Indexed keywords

CELECOXIB;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PENETRATION; HISTOPATHOLOGY; INFRARED SPECTROSCOPY; LIPID BILAYER; MALE; MAXIMUM PLASMA CONCENTRATION; MICROPHOTOGRAPHY; NANOEMULSION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RAT; SKIN PERMEABILITY; STRATUM CORNEUM; THERMOGRAPHY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; EMULSIONS; NANOSTRUCTURES; PERMEABILITY; PYRAZOLES; RATS; SKIN; SULFONAMIDES;

EID: 56349112890     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860802473402     Document Type: Article

References (37)

1. Aqil, M., Ali, A. and Sultana, Y. (2004) Matrix type transdermal drug delivery system of metoprolol tartrate: Skin toxicity and in vivo characterization. Ethiop Pharm J, 22, pp. 53-60.
2. Baboota, S., Shakeel, F., Ahuja, A., Ali, J. and Shafiq, S. (2007) Design development and evaluation of novel nanoemulsions formulations for transdermal potential of celecoxib. Acta Pharm, 8, pp. 316-332.
3. Baboota, S., Alazaki, A., Kohli, K., Ali, J., Dixit, N. and Shakeel, F. (2007) Development and evaluation of a microemulsion formulation for transdermal delivery of terbenafine. PDA J Pharm Sci Technol, 61, pp. 276-285.
4. Babua, RJ and Pandit, JK (2005) Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems. Int J Pharm, 288, pp. 325-334.
5. Bruce, JA (1993) Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci, 82, pp. 979-987.
6. Cole, L. and Heard, C. (2007) Skin permeation enhancement potential of aloe vera and a proposed mechanism of action based upon size exclusion and pull effect. Int J Pharm, 333, pp. 10-16.
7. Constantinides, PP (1995) Lipid microemulsions for improving drug dissolution and oral absorption and biopharmaceutical aspects. Pharm Res, 12, pp. 1561-1572.
8. Cotte, M., Dumas, P., Besnard, M., Tchoreloff, P. and Walter, P. (2004) Synchrotron FT-IR microscopic study of chemical enhancers in transdermal drug delivery: Example of fatty acids. J Control Release, 97, pp. 269-281.
9. Cumming, KI and Winfield, AJ (1994) In vitro evaluation of a series of sodium carboxylates as dermal penetration enhancers. Int J Pharm, 108, pp. 141-148.
10. Fang, JY, Hung, CF, Chiu, HC, Wang, JJ and Chan, TF (2003) Efficacy and irritancy of enhancers on the in vitro and in vivo percutaneous absorption of curcumin. J Pharm Pharmacol, 55, pp. 593-601.
11. Gaurel, A., Martel, AM and Castaner, J. (1997) Celecoxib, anti-inflammatory, cyclo-oxygenase-2 inhibitor. Drugs Future, 22, pp. 711-714.
12. Ghosh, MN (2005) Fundamentals of experimental pharmacology, p. 192. Hilton and company, Kolkata
13. Golden, GM, Guzek, DB, Harris, RR, McKie, JE and Potts, RO (1986) Lipid thermotropic transition in human stratum corneum. J Invest Dermatol, 86, pp. 255-259.
14. Goodman, M. and Barry, BW (1989) Action of penetration enhancers on human stratum corneum as assessed by differential scanning calorimetry. Percutaneous absorption, pp. 567-593. Marcel Dekker, New York/Basel
15. Jain, AK, Thomas, NS and Panchagula, R. (2001) Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J Control Release, 79, pp. 93-101.
16. Jalalizadeh, H., Amini, M., Ziace, V., Farsam, SA and Shafice, A. (2004) Determination of celecoxib in human plasma by high-performance liquid chromatography. J Pharm Biomed Anal, 35, pp. 665-670.
17. Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y. and Masuda, K. (2002) Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design. J Control Release, 81, pp. 65-74.
18. Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y. and Masuda, K. (2002) Microemulsion formulation for enhanced absorption of poorly soluble drugs II. In vivo study. J Control Release, 81, pp. 75-82.
19. Kommuru, TRK, Gurley, B., Khan, MA and Reddy, IK (2001) Selfemulsifying drug delivery systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int J Pharm, 212, pp. 233-246.
20. Lawrence, MJ and Rees, GD (2000) Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev, 45, pp. 89-121.
21. Lee, PJ, Langer, R. and Shastri, VP (2005) Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. J Pharm Sci, 94, pp. 912-917.
22. Monti, D., Saettone, MF, Giannaccini, B. and Galli-Angeli, D. (1995) Enhancement of transdermal penetration of dapiprazole through hairless mouse skin. J Control Release, 33, pp. 71-77.
23. Narishetty, STK and Panchagnula, R. (2004) Transdermal delivery of zidovudine: Effect of terpenes and their mechanism of action. J Control Release, 95, pp. 367-379.
24. Pagano, R. and Thompson, TE (1968) Spherical bilayer membranes: Electrical and isotopic studies of ion permeability. J Mol Biol, 38, pp. 41-57.
25. Paget, GE and Barnes, JM (1964) Evaluation of drug activities: Pharmacometrics, 1, Academic Press, New York/London
26. Panchagnula, R., Salve, PS, Thomas, NS, Jain, AK and Ramarao, PU (2000) Transdermal delivery of naloxone: Effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm, 219, pp. 95-105.
27. Panchagnula, R., Salve, PS, Thomas, NS, Jain, AK and Ramarao, P. (2001) Transdermal delivery of naloxone: Effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm, 219, pp. 95-105.
28. Robinson, JR (1996) Introduction: Semi-solid formulations for oral drug delivery. BT Gattefosse, 89, pp. 11-13.
29. Shafiq, S., Shakeel, F., Talegaonkar, S., Ahmad, FJ, Khar, RK and Ali, M. (2007) Design and development of oral oil in water ramipril nanoemulsion formulation: In vitro and in vivo assessment. J Biomed Nanotechnol, 3, pp. 28-44.
30. Shafiq, S., Shakeel, F., Talegaonkar, S., Ali, J., Baboota, S., Ahuja, A., Khar, RK and Ali, M. (2007) Formulation development and optimization using nanoemulsion technique: A technical note. AAPS Pharm Sci Technol, 8, p. E28.
31. Shafiq, S., Shakeel, F., Talegaonkar, S., Ahmad, FJ, Khar, RK and Ali, M. (2007) Development and bioavailability of ramipril nanoemulsion formulation. Eur J Pharm Biopharm, 66, pp. 227-242.
32. Shakeel, F., Baboota, S., Ahuja, A., Ali, J., Aqil, M. and Shafiq, S. (2007) Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS Pharm Sci Technol, 8, p. E104.
33. Stott, PW, Williams, AC and Barry, BW (2001) Mechanistic study into the enhanced transdermal permeation of a model β-blocker, propranolol, by fatty acids: A melting point depression effect. Int J Pharm, 219, pp. 161-176.
34. Vaddi, HK, Ho, PC and Chan, SY (2002) Terpenes in propylene glycol as skin-penetration enhancers: Permeation and partition of haloperidol, fourier transform infrared spectroscopy and differential scanning calorimetry. J Pharm Sci, 91, pp. 1639-1651.
35. Xiong, GL, Quan, D. and Maibach, HI (1996) Effects of penetration enhancers on in vitro percutaneous absorption of low molecular weight heparin through human skin. J Control Release, 42, pp. 289-296.
36. Yamane, MA, Williams, AC and Barry, BW (1995) Terpenes penetration enhancers in propylene glycol/water co-solvent systems: Effectiveness and Mechanism of action. J Pharm Pharmacol, 47, pp. 978-989.
37. Zhao, K. and Singh, J. (1998) Mechanisms of percutaneous absorption of tamoxifen by terpenes: Eugenol, -limonene and menthone. J Control Release, 55, pp. 253-264.